|
The New England Biotech Association (NEBA) is a coalition of biotechnology companies, academic institutions, pharmaceutical companies, and trade organizations from all six New England States. NEBA serves as a regional policy and public affairs voice for the biotechnology and biopharmaceutical industry.〔http://www.masshightech.com/stories/2008/06/23/focus3-Opportunities-and-challenges-face-biotech-companies-outside-of-Boston.html〕 NEBA is a non-profit, member driven organization, with over 600 members.〔http://www.marketwatch.com/news/story/New-Regional-Biotech-Association-Formed/story.aspx?guid=〕 The Chairman of NEBA is Paul Pescatello, Director of Connecticut United for Research Excellence -(CURE.) 〔http://www.curenet.org CURE〕 In 2010, NEBA advocated against measures that would harm the biotechnology industry in (Maine ) and other New England states. The organization also launched a website (www.MassRxHelp.org ) to help consumers save money on prescription medications.〔http://bostonherald.com/business/healthcare/view.bg?articleid=1243565 〕〔http://www.bizjournals.com/boston/stories/2010/03/29/daily24.html〕 ==External links== * (Official web site ) 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「New England Biotech Association」の詳細全文を読む スポンサード リンク
|